Medical Device Investing Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment
Medical Device Investing CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds
Medical Device Investing AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across Europe
Medical Device Investing Real-World Data Shows Significant Reduction in Hospital Stay Using AVITA Medical's RECELL® System
